Inadequate antimicrobial treatment for nosocomial infection is a mortality risk factor for systemic lupus erythematous patients admitted to intensive care unit

American Journal of the Medical Sciences

Volumn 340, Issue 1, 2010, Pages 64-68

  Feng, Po Hao ^a   Lin, Shu Min ^a   Yu, Chih Teng ^a   Yu, Kuang Hui ^a   Huang, Chien Da ^a   Tsai, Ying Huang ^a   Kuo, Han Pin ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PIPERACILLIN; PREDNISOLONE;

ABDOMINAL INFECTION; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; CARDIOVASCULAR DISEASE; CATHETER INFECTION; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; EPILEPTIC STATE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IN VITRO STUDY; INFECTION RISK; INTENSIVE CARE UNIT; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PNEUMONIA; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SOFT TISSUE INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 77954660258     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181e0ef9b     Document Type: Article

References (25)

1. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;8:2550-2557
2. Cervera R, Abarca-Costalago M, Abramovicz D, et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project." Autoimmun Rev 2006;3:180-186 (Pubitemid 43234182)
3. Uramoto KM, Michet CJ Jr, Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;1:46-50.
4. Nossent J, Cikes N, Kiss E, et al. Current causes of death in systemic lupus erythematosus in Europe, 2000-2004: relation to disease activity and damage accrual. Lupus 2007;5:309-317
5. Ansell SM, Bedhesi S, Ruff B, et al. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 1996;6:981-984
6. Williams FM, Chinn S, Hughes GR, et al. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis 2002;5:414-421
7. Hsu CL, Chen KY, Yeh PS, et al. Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care 2005;3:R177- 83.
8. Thong BY, Tai DY, Goh SK, et al. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 2001;3:254-259
9. Alzeer AH, Al-Arfaj A, Basha SJ, et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus 2004;7: 537-542
10. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;2:462-474
11. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 2008;2:436-441
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;9:1725.
13. Badsha H, Teh CL, Kong KO, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004;6:414-421
14. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;3(Pt 1):818-824 (Pubitemid 24082248)
15. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;6:1481-1483
16. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;3:128-140
17. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;19:2588-2598
18. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;1:262-268
19. DeRyke CA, Lodise TP Jr, Rybak MJ, et al. Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 2005;3:1414-1422
20. Depuydt PO, Blot SI, Benoit DD, et al. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med 2006;3:653-659
21. Faria S, Sodano L, Gjata A, et al. The first prevalence survey of nosocomial infections in the University Hospital Centre 'Mother Teresa' of Tirana, Albania. J Hosp Infect 2007;3:244-250
22. Luna CM, Aruj P, Niederman MS, et al. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006;1:158-164
23. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;10:818-829
24. Fernandez M, Alarcon GS, Apte M, et al. Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. Arthritis Rheum 2007;2:614-621
25. Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;10:1638-1652